Skip to main content

Bowel Segments (GI Tissue)

Gastrointestinal tissue — harvested ileum, ileocolon, colon, or appendix — is the enduring gold standard for urinary-tract reconstruction, despite its long-term metabolic and mechanical complications.[1]

Why Bowel?​

Bowel segments are:

  • Abundant — plentiful donor tissue
  • Well-vascularized — based on mesenteric arcade
  • Tubular — reconstitutes urinary conduits and reservoirs
  • Adaptable — can be detubularized, folded, and reconfigured into bladders, channels, and conduits
  • Tolerated — patients survive permanent bowel loss of the segment harvested

Major Applications​

Urinary Diversion​

  • Ileal conduit (Bricker) — most common incontinent diversion
  • Orthotopic neobladder — continent diversion replacing the bladder after cystectomy (Studer, Hautmann, others)
  • Continent cutaneous reservoir (Indiana pouch, Kock pouch, Mainz pouch)

Bladder Augmentation​

  • Ileocystoplasty — detubularized ileum patched onto the opened bladder to increase compliance and capacity
  • Indications: neurogenic bladder, poor compliance, low capacity

Continent Catheterizable Channels​

  • Mitrofanoff (appendix) — the gold standard
  • Monti (ileum) — when appendix is unavailable or insufficient
  • Indications: neurogenic bladder with inability to catheterize per urethra, complex urinary diversion

Urethral Reconstruction (Limited)​

  • Bowel mucosa is generally unsuitable for urethral reconstruction in adults (bulky, mucus-producing, unsuitable for male urethra)
  • Historical and occasional use in specialized reconstruction

Long-Term Complications​

The metabolic, mechanical, and oncologic sequelae of bowel in the urinary tract are extensively documented:

  • Hyperchloremic metabolic acidosis (ileal and colonic segments)
  • Mucus production — chronic catheter and urine changes
  • Stone formation — mucus and bacterial colonization
  • Vitamin B12 deficiency (terminal-ileal resection)
  • Bile-salt diarrhea (terminal-ileal resection)
  • Secondary malignancy — adenocarcinoma risk increases decades after diversion, particularly in ureterosigmoidostomy (now rare)
  • Conduit / pouch stones, strictures, and infection

Why Not Better Alternatives?​

  • Tissue-engineered bladders and urothelial constructs remain investigational despite 20+ years of work[2][3]
  • Decellularized matrices and bioscaffolds have not reached clinical routine for bladder substitution
  • Bowel remains the durable, reproducible, and globally-available solution

References​

1. Davis NF, Cunnane EM, Quinlan MR, et al. Biomaterials and Regenerative Medicine in Urology. Advances in Experimental Medicine and Biology. 2018;1107:189–198. doi:10.1007/5584_2017_139

2. Sharma S, Basu B. Biomaterials Assisted Reconstructive Urology: The Pursuit of an Implantable Bioengineered Neo-Urinary Bladder. Biomaterials. 2022;281:121331. doi:10.1016/j.biomaterials.2021.121331

3. Duan L, Wang Z, Fan S, Wang C, Zhang Y. Research Progress of Biomaterials and Innovative Technologies in Urinary Tissue Engineering. Frontiers in Bioengineering and Biotechnology. 2023;11:1258666. doi:10.3389/fbioe.2023.1258666

See also: Bowel Anatomy, Bowel Anastomosis, Decellularized ECM.